The guideline recommendations advise universal use of hydroxychloroquine, minimizing steroids, and earlier introduction of ...

T-cell therapy for rheumatologic disease is now expanding out of academe into the commercial space, with encouraging new data ...

AstraZeneca Plc said a handful of patients with lupus went into remission after getting an experimental treatment, as the UK ...

GSK plc (LSE/NYSE: GSK) today announced the launch of the Linked by Lupus: Optimal Care Initiative to help support ...

BARCELONA -- A novel antibody-based drug targeting the CD40 ligand helped close to half of patients with treatment-refractory ...

Most lupus patients are women and many are Black women. They can suffer rashes, fatigue and kidney problems but may not know ...

Merck KGaA has shed more light on the failure of its lupus drug in one cohort of patients, while pointing to secondary ...

The Johns Hopkins Department of Dermatology is seeking volunteers with cutaneous lupus to participate in a research study ...

The Member of Parliament (MP) for Korle Klottey in Accra, Dr Zanetor Agyeman-Rawlings, has called for the inclusion of lupus ...

An autoantibody associated with systemic lupus erythematosus may help improve the performance of immune checkpoint inhibitor ...

Researchers have found in a recent meta-analysis that belimumab is more effective than placebo in treating systemic lupus ...